Type 2 diabetes mellitus is a metabolic disorder of glucose management, whose prevalence is increasing inexorably worldwide. Adherence to therapies, along with a healthy lifestyle can help prevent the onset of disease. This preliminary study proposes the use of explainable artificial intelligence techniques with the aim of (i) characterizing diabetic patients through a set of easily interpretable rules and (ii) providing individualized recommendations for the prevention of the onset of the disease through the generation of counterfactual explanations, based on minimal variations of biomarkers routinely collected in primary care. The results of this preliminary study parallel findings from the literature as differences in biomarkers between patients with and without diabetes are observed for fasting blood sugar, body mass index, and high-density lipoprotein levels.

Characterization of Type 2 Diabetes Using Counterfactuals and Explainable AI

Lenatti M.
Primo
;
Carlevaro A.;Paglialonga A.
Penultimo
;
Mongelli M.
Ultimo
2022

Abstract

Type 2 diabetes mellitus is a metabolic disorder of glucose management, whose prevalence is increasing inexorably worldwide. Adherence to therapies, along with a healthy lifestyle can help prevent the onset of disease. This preliminary study proposes the use of explainable artificial intelligence techniques with the aim of (i) characterizing diabetic patients through a set of easily interpretable rules and (ii) providing individualized recommendations for the prevention of the onset of the disease through the generation of counterfactual explanations, based on minimal variations of biomarkers routinely collected in primary care. The results of this preliminary study parallel findings from the literature as differences in biomarkers between patients with and without diabetes are observed for fasting blood sugar, body mass index, and high-density lipoprotein levels.
2022
Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni - IEIIT
Inglese
Challenges of Trustable AI and Added-Value on Health
Contributo
32nd Medical Informatics Europe (EFMI MIE 2022) Conference
294
98
103
6
http://www.scopus.com/record/display.url?eid=2-s2.0-85131107421&origin=inward
IOS Press
Esperti anonimi
27-30/05/2022
Nizza, Francia
Internazionale
Diabetes
Counterfactual Explanations
eXplainable AI
Elettronico
6
none
Lenatti, M.; Carlevaro, A.; Keshavjee, K.; Guergachi, A.; Paglialonga, A.; Mongelli, M.
273
info:eu-repo/semantics/conferenceObject
04 Contributo in convegno::04.01 Contributo in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/417045
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact